![click for more info about Turnstone Biologics](https://facit.ca/wp-content/uploads/2021/11/Turnstone.png)
Turnstone Biologics Inc
turnstonebio.com
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
Series A,B,C, IPO
Fund:
Compass Rose
Developing next-generation tumor infiltrating lymphocytes (TIL) therapies by selecting the most potent and tumor-reactive T cells for potential treatment across multiple solid tumors